| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |